Tomoyuki Fujikawa

Statistics

Publications

Citations

197

H-Index

Active since

1988

Affiliations

Institute of Medicinal Molecular Design(Current)

The University of Osaka

Hokkaido University

Tomoyuki Fujikawa is an author at Institute of Medicinal Molecular Design specializing in life sciences, pharmacology, and nuclear factor kappa b inhibition.

Publications per year

1988–2016

Publications

Murine fetal resorption and experimental pre-eclampsia are induced by both excessive Th1 and Th2 activation

Satoshi Hayakawa, Tomoyuki Fujikawa, Hideoki Fukuoka et al. · Journal of Reproductive Immunology · 2000 · 69 citations

Life Sciences, Immunology, Obstetrics +15

Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats.

Anton Lennikov, Nobuyoshi Kitaichi, Kousuke Noda et al. · PubMed · 2012 · 25 citations · Full text

Life Sciences, Immunology, Pharmacology +17

IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment

Yasuto Kinose, Kenjiro Sawada, Hiroshi Makino et al. · Molecular Cancer Therapeutics · 2015 · 24 citations

Medicine, Oncology, Pharmacology +17

IκB Kinase-β Inhibitor IMD-0354 Beneficially Suppresses Retinal Vascular Permeability in Streptozotocin-Induced Diabetic Mice

Anton Lennikov, Miki Hiraoka, Akira Abe et al. · Investigative Ophthalmology & Visual Science · 2014 · 20 citations

Medicine, Ophthalmology, Pharmacology +16

The novel IκB kinase β inhibitor IMD-0560 prevents bone invasion by oral squamous cell carcinoma

Yukiyo Tada, Shoichiro Kokabu, Goro Sugiyama et al. · Oncotarget · 2014 · 17 citations · Full text

Medicine, Oncology, Pharmacology +12

1–5 of 8